4 citations
,
September 2016 in “Journal der Deutschen Dermatologischen Gesellschaft” This study found that 7.9% of dermatological outpatients at a German hospital had clinically relevant body dysmorphic concerns, highlighting the need for psychotherapeutic support due to poor social adaptation and high motivation for change.
39 citations
,
November 2017 in “Journal of The American Academy of Dermatology” This review presents standardized methods for assessing and tracking hair loss in alopecia areata but reports no clinical results, with the authors noting time limitations in clinical practice.
6 citations
,
June 2018 in “PLOS ONE” This study demonstrated that the Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata cases with high sensitivity and specificity in a dermatology clinic setting.
June 2026 in “Clinical Cosmetic and Investigational Dermatology” This study found that escalating baricitinib to 6 mg daily improved hair loss in 75% of patients with severe refractory alopecia areata who responded poorly to standard treatments, while also noting manageable short-term safety concerns under close monitoring.
6 citations
,
October 2020 in “Journal of the European Academy of Dermatology and Venereology” This article introduces teletrichoscopy as a method for diagnosing hair disorders during the COVID-19 pandemic and reports no new clinical results.